首页> 外文期刊>Journal of Anaesthesiology Clinical Pharmacology >An evaluation of brachial plexus block using a nerve stimulator versus ultrasound guidance: A randomized controlled trial
【24h】

An evaluation of brachial plexus block using a nerve stimulator versus ultrasound guidance: A randomized controlled trial

机译:使用神经刺激器对超声引导下臂丛神经阻滞的评估:一项随机对照试验

获取原文
           

摘要

Background and Aims: This study was carried out to evaluate the difference in efficacy, safety, and complications of performing brachial plexus nerve blocks by using a nerve locator when compared to ultrasound (US) guidance. Material and Methods: A total of 102 patients undergoing upper limb surgery under supraclavicular brachial plexus blocks were randomly divided into two groups, one with US and the other with nerve stimulator (NS). In Group US, "Titan" Portable US Machine, Sonosite, Inc. Kensington, UK with a 9.0 MHz probe was used to visualize the brachial plexus and 40 ml of 0.25% bupivacaine solution was deposited around the brachial plexus in a graded manner. In Group (NS), the needle was inserted 1-1.5 cm above mid-point of clavicle. Once hand or wrist motion was detected at a current intensity of less than 0.4 mA 40 ml of 0.25% bupivacaine was administered. Onset of sensory and motor block of radial, ulnar and median nerves was recorded at 5-min intervals for 30-min. Block execution time, duration of block (time to first analgesic), inadvertent vascular puncture, and neurological complications were taken as the secondary outcome variables. Results: About 90% patients in US group and 73.1% in NS group, had successful blocks P = 0.028. The onset of block was faster in the Group US as compared to Group NS and this difference was significant (P 0.007) only in the radial nerve territory. The mean duration of the block was longer in Group US, 286.22 ± 42.339 compared to 204.37 ± 28.54-min in Group NS (P Conclusion: Ultrasound guidance for supraclavicular brachial plexus blockade provides a block that is faster in onset, has a better quality and lasts longer when compared with an equal dose delivered by conventional means.
机译:背景与目的:本研究旨在评估与超声(US)引导相比,使用神经定位器进行臂丛神经阻滞的疗效,安全性和并发症的差异。材料与方法:将102例在锁骨上臂丛神经阻滞下进行上肢手术的患者随机分为两组,一组进行超声检查,另一组进行神经刺激器治疗。在美国组中,使用带有9.0MHz探针的英国肯辛顿Sonosite公司的“ Titan”便携式美国机器来可视化臂丛,并且将40ml的0.25%布比卡因溶液以分级的方式沉积在臂丛周围。在组(NS)中,将针头插入锁骨中点上方1-1.5 cm。一旦在小于0.4 mA的电流强度下检测到手部或腕部运动,就应施用40 ml的0.25%布比卡因。以5分钟为间隔30分钟记录radial,尺神经和正中神经的感觉和运动阻滞的发作。次要结局变量包括阻滞执行时间,阻滞持续时间(首次镇痛时间),无意穿刺血管和神经系统并发症。结果:US组约90%的患者和NS组约73.1%的患者成功阻滞P = 0.028。与NS组相比,US组的阻滞发作更快,并且这种差异仅在the神经区域显着(P 0.007)。 US组的平均阻塞持续时间更长,为286.22±42.339,而NS组的平均阻塞持续时间为204.37±28.54-min(P结论:超声引导下锁骨上臂丛神经阻滞提供了一种起效更快,质量更好,与通过常规方式输送的等剂量药物相比,持续时间更长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号